SCHEMBL23352779

SCHEMBL23352779

CCCCC(C)(C)C(O)/C=C/[C@H]1C(O)CC(=O)C1C/C=C\CCCC(=O)O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGFR P43088 3/20 0.73
▸ PTGER3 P43115 3/20 0.73
▸ PTGER4 P35408 3/20 0.73
▸ PTGER2 P43116 3/20 0.73
▸ PTGIR P43119 3/20 0.73
▸ TSHR P16473 3/20 0.73
▸ TBXA2R P21731 2/20 0.73
▸ PTGER1 P34995 2/20 0.73
▸ HPGD P15428 2/20 0.73
▸ MAPK1 P28482 2/20 0.73
▸ NR1I2 O75469 1/20 0.73
▸ ESR1 P03372 1/20 0.73
▸ PGR P06401 1/20 0.73
▸ OPRK1 P41145 1/20 0.73
▸ PDE4D Q08499 1/20 0.73
▸ MEN1 O00255 1/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ ABCC3 O15438 1/20 0.52
▸ ABCC4 O15439 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL674246 1.00 PTGFR (0.73) PTGFRPTGER3PTGER4PTGER2PTGIR
SCHEMBL10742477 1.00 PTGFR (0.73) PTGFRPTGER3PTGER4PTGER2PTGIR
SCHEMBL11079261 1.00 PTGFR (0.73) PTGFRPTGER3PTGER4PTGER2PTGIR
SCHEMBL3368201 1.00 PTGFR (0.73) PTGFRPTGER3PTGER4PTGER2PTGIR
SCHEMBL29424279 1.00 PTGFR (0.73) PTGFRPTGER3PTGER4PTGER2PTGIR
SCHEMBL29420457 1.00 PTGFR (0.73) PTGFRPTGER3PTGER4PTGER2PTGIR
SCHEMBL11379818 0.91 PTGER4 (0.70) PTGFRPTGER3PTGER4PTGER2PTGIR
Trimoprostil SCHEMBL11024670 0.91 PTGER3 (0.64) PTGFRPTGER3PTGER4PTGER2PTGIR
Trimoprostil SCHEMBL564049 0.91 PTGER3 (0.64) PTGFRPTGER3PTGER4PTGER2PTGIR
Trimoprostil SCHEMBL11226793 0.91 PTGER3 (0.64) PTGFRPTGER3PTGER4PTGER2PTGIR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210139435-A1 PROSTAGLANDIN ANALOGS AND USES THEREOF Lifex Biolabs, Inc. 2021-05-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139435-A1 PROSTAGLANDIN ANALOGS AND USES THEREOF PTGDR, NR3C1, PTGIR PTGFR 19/4885PTGER3 23/4885PTGER4 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback